AXS vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
AXS exhibits a weak Piotroski F-Score of 2/9, signaling significant financial health concerns, while the absence of an Altman Z-Score prevents a full distress risk assessment. Despite this, the company trades at a low P/E of 8.53 versus sector average of 20.94, shows strong recent earnings growth (YoY +83.3%), and beats estimates consistently, with a favorable analyst target of $120.91. However, deteriorating technical trend (0/100), bearish insider activity, and weak liquidity ratios (Current Ratio: 0.70, Quick Ratio: 0.19) counterbalance valuation appeal. The stock appears reasonably valued near $102 but faces structural balance sheet risks and negative insider sentiment.
JPM shows bullish fundamentals based on deterministic rules. Financial strength is weak (F-Score 2/9). Key strengths include strong valuation and growth metrics. Price trades at a 109.8% premium to fair value estimate ($140.21), limiting near-term upside from a valuation perspective.
Compare Another Pair
Related Comparisons
AXS vs JPM: Head-to-Head Comparison
This page compares AXIS Capital Holdings Limited (AXS) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.